Boston Scientific Corporation
(NYSE : BSX)

( )
BSX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
-0.36%86.990.6%$601.67m
TMOThermo Fisher Scientific Inc.
0.05%240.781.0%$520.75m
ABTAbbott Laboratories
0.15%71.530.8%$488.96m
ISRGIntuitive Surgical, Inc.
-1.06%536.782.4%$449.04m
ALGNAlign Technology, Inc.
-1.79%216.166.3%$315.21m
BAXBaxter International Inc.
-1.35%69.681.7%$275.30m
BDXBecton, Dickinson and Company
-1.19%239.201.1%$274.30m
SYKStryker Corporation
-1.00%165.871.3%$257.72m
TFXTeleflex Incorporated
-0.16%257.505.4%$253.26m
BSXBoston Scientific Corporation
-1.11%37.271.1%$251.77m
EWEdwards Lifesciences Corporation
-0.07%168.301.2%$228.11m
DXCMDexCom, Inc.
0.87%150.828.5%$186.51m
ABMDABIOMED, Inc.
0.72%336.133.3%$175.58m
ZBHZimmer Biomet Holdings, Inc.
-1.36%103.911.7%$148.50m
COOCooper Companies, Inc.
-0.76%267.572.2%$117.59m

Company Profile

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Cardiovascular, Rhythm Management, and MedSurg. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease, and other cardiovascular disorders including structural heart conditions. The Rhythm Management segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal, and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.